|
|
|||||||||
|
|
NeoReviews Vol.9 No.1 2008 e8
© 2008 American Academy of Pediatrics
* Professor of Pediatrics, Division of Neonatology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa and University of Iowa Children's Hospital, Iowa City, Ia
| Abstract |
|---|
|
|
|---|
Abbreviations: AAP: American Academy of Pediatrics ADE: adverse drug event AE: adverse (medical) event AHRQ: Agency for Healthcare Research and Quality BSMA: barcode-scanning medication administration CI: confidence interval CPOE: computer provider/physician/prescriber order entry eMAR: electronic medication administration record ICU: intensive care unit IT: information technology ME: medication error NICU: neonatal intensive care unit OR: odds ratio PDSA: Plan-Do-Study-Act PICU: pediatric intensive care unit RR: relative risk VA: Veterans Affairs VLBW: very low birthweight VON: Vermont Oxford Network
| Objectives |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Evidence That Neonates Are Harmed |
|---|
|
|
|---|
Table 1. Definitions of Patient Safety Terms
|
Table 2. Adverse Medical Events Detected with an NICU-specific Trigger Tool (1)
|
NICU=neonatal intensive care unit
Table 3. Incidence of Preventable Adverse Drug Events Detected in Pediatric Inpatients
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CPOE=computer provider/physician/prescriber order entry, NICU=neonatal intensive care unit, PICU=pediatric intensive care unit.
This review considers the pathways that lead to AEs; general approaches to their mitigation; specific interventions that have been studied to reduce the incidence of preventable ADEs, intravascular catheter complications, and nosocomial infections; human factors that contribute to errors and approaches to their mitigation; and steps that NICUs can take to develop a patient safety program.
| Pathways to Harm |
|---|
|
|
|---|
|
| Human Fallibility |
|---|
|
|
|---|
| Medical Care in the NICU is a Complex Adaptive System |
|---|
|
|
|---|
| Prevention of Errors: Human Factors Engineering and Systems |
|---|
|
|
|---|
Reliability and Failure
Industrial engineers have evolved a language for characterizing the reliability of a complex system and its processes. Reliability may be quantified as the ratio of the number of actions in a system or process that achieves the desired result divided by the total number of actions taken. If a complex system, such as medication administration in the NICU, involves a series of actions taken in sequence, such as ordering, dispensing, and administering a drug to a patient, the overall reliability of the medication process is the product of the reliability of each of the three steps. It is immediately apparent that overall reliability of the process might be improved by reducing the number of sequential steps or by improving the reliability of the individual steps. The failure of a process is characterized by several measures. The failure rate is the percentage of occurrences that failed to be executed as expected. Failure also can be expressed by orders of magnitude: a 10–1 level reliability system is one that encounters 1 failure in each 10 opportunities, a 10–2 level reliability system is one that encounters 1 failure with each 100 opportunities, and a 10–3 level reliability system is one that encounters 1 failure in each 1,000 opportunities.
Luria and associates (6) compiled examples of various levels of reliability from health care and other industries. AEs in the NICU resulting in neonatal deaths occur at reliability level 10–3, similar to AEs resulting in deaths in general surgery. AEs resulting in adult patient deaths occur less frequently in obstetrics and in anesthesiology, which have level 10–4 reliability. The most reliable medical processes cited are those for blood transfusions and radiotherapy, which are level 10–5, but these medical processes all fall short of the most reliable examples from other industries, such as the nuclear industry and large-jet commercial aviation, both of which operate at reliability level 10–6. In the NICU, the failure rates for nosocomial infection, unplanned extubation, intravenous catheter complications, and ADEs (per dose administered) are each sufficiently large that these processes have reliability levels 10–1 or 10–2 for any harm and perhaps level 10–3 for death as the consequence of failure.
Strategies to Improve Reliability
As with all quality improvement efforts, measurement and quantification is the first step to improve patient safety. The Plan-Do-Study-Act (PDSA) or similar cycle may be employed to devise the appropriate intervention for improvement. To improve the reliability of a system or process that has level 10–1 reliability, standardization of the process to a practice that has been shown to be effective often is used. Reliability level 10–2 processes may use redundancy, reminders, and decision aids to prevent failures. To improve reliability level 10–3 processes, failures should be measured and studied for understanding and the system redesigned to mitigate recurrences.
Mindfulness
High-reliability organizations may be characterized as those that exhibit a state of mindfulness in which they are constantly concerned with identifying failures, they devote time to observe workers performing tasks and to train workers in the best approaches to task performance, and they allow workers to identify and solve problems. (6) A NICU that adopts these characteristics to reduce nosocomial infection failures would: 1) measure the rate of nosocomial infection, 2) observe hand washing practices by all who enter or work in the NICU, 3) standardize skin preparation for placement and maintenance of indwelling catheters to standards that have proven to be effective, 4) use antibiotics conservatively according to sensitivities of cultured organisms, 5) re-train workers who are observed to break technique or do not monitor and respond to culture results after prescribing antibiotics, and 6) remeasure the incidence of nosocomial infection over time to determine if the intervention was effective and persisted. If antifungal prophylaxis concurrently administered with antibiotics has been shown to be an effective method of reducing fungal infections in neonates, but standard use is forgotten frequently, a high-reliability organization might employ CPOE prompts to remind the prescriber to order antifungals or add antifungals as a default order that is electronically signed or deleted when antibiotic orders are signed, as well as integrate microbiology culture result pop-up reports into the electronic medical record with a reminder to adjust the antibacterial regimen accordingly.
| Prevention of MEs and ADEs: The Proposed Reliable System |
|---|
|
|
|---|
The IT system recommended and currently being deployed in hospitals, usually piecemeal, is depicted in Figure 2. In the full system, a clinician orders a drug using CPOE and clinical decision support software that is integrated with the pharmacy software. The pharmacy software controls a robot that reads the electronically delivered order and prepares a specific unit dose of the drug for the specific patient to be administered by a specific route at a specific time. A barcode label that contains all four of these pieces of information, as well as the patient's hospital identifiers, is applied to the unit dose. The unit dose is delivered to the patient's nursing unit, and the patient's nurse or respiratory therapist (for inhaled medications) retrieves the medication; takes it to the patient's bedside; and scans the barcode on his/her identification badge, the barcode on the patient's wristband, and the barcode on the unit dose. The barcode scanner transmits this information to an adjacent computer operating with barcode-scanning medication administration (BSMA) system software to match the information with the patient's ordered medications on the electronic medication administration record (eMAR) and signals to the nurse or respiratory therapist that the five "rights," the five pieces of information on the barcode label, match with the order and the patient and to proceed with administration of the drug dose. The software instructs the administering professional to confirm that the medication dose was given, and after the confirmation, the software enters the dose as given on the eMAR. Such systems may be designed to:
|
CPOE in the absence of the one or more downstream system components has been studied in adult and pediatric populations. CPOE has been shown to decrease MEs on adult inpatient units and PICUs and in a retrospective review of gentamicin MEs in one NICU. Potts and associates (8) compared medication order errors and potential ADEs for a period before CPOE implementation with a period after CPOE was introduced in a PICU. They found a 40.9% reduction in orders that had the potential for ADEs and a 99.4% reduction in all medication prescribing errors after the system was introduced. However, the study was not powered sufficiently to detect actual preventable ADEs that resulted from medication prescribing errors. Upperman and coworkers (5) reported a decrease in "harmful" ADEs in a tertiary pediatric hospital from 0.05±0.017/1,000 doses to 0.03±0.003/1,000 doses (P=0.05) after the implementation of CPOE.
Two reports of the effectiveness of CPOE introduction in PICUs on mortality provide opposite conclusions. Han and associates (9) reported that adjusted mortality increased significantly from 2.8% to 6.57% when a CPOE system was installed simultaneously with changes in certain policies regarding admission and pharmaceutical availability. However, Del Beccaro and colleagues (10) implemented the same system a year later in another PICU, after learning from the experience of the previous investigators, and they detected a nonsignificant decrease in overall mortality that was not adjusted for potential confounders, but for periods that were similar in average Pediatric Risk of Mortality (version 3) scores. The policy changes made coincidentally with the implementation of CPOE in the Han study, lack of order sets, and limited bandwidth capacity of the wireless network appeared to delay order writing and medication delivery to critically ill patients.
CPOE introduces a new interface between humans and machines, thereby creating new opportunities for error. Indeed, early versions of CPOE were found in one study to introduce 22 new types of error. (11) Other investigators analyzed the MEs that occurred among randomly sampled pediatric admissions 3 to 12 months after the introduction of CPOE in an urban teaching hospital. (12) The sample included NICU admissions. Among the 6,916 medication orders written for 352 patients whose records were reviewed, there were 104 total MEs, 20 of which were computer-related. Four types of computer-related MEs were found: duplicate medication orders, drop-down menu selection error, keypad entry error, and order set errors. Of the 26 preventable ADEs that were identified, none was attributed to the computer-related MEs, but four ordering errors that resulted in preventable ADEs were not prevented by the CPOE system. Analysis by Zhan and colleagues (13) of voluntarily reported computer-related MEs submitted in 2003 to MedmarxTM, sponsored by the United States Pharmacopeia, by 120 hospitals that had CPOE identified the following as the common errors: faulty computer interface, miscommunication between CPOE and other systems, failure to alert, wrong click or pick on multiple-choice items on the computer screen, and wrong patient.
Barcode Scanning Medication Dispensing and Administration Systems
The second sequential component of the complete system for medication administration recommended to reduce preventable ADEs is a pharmacy robot that receives the order from CPOE software and dispenses a barcode-labeled unit dose of the ordered drug. Such robots reduce dispensing errors and have been found to reduce significantly target-dispensing errors (ie, those that the technology was designed to address) by 93% to 96% and to reduce target potential ADEs by 86% to 97% when all dispensed doses for the same order were scanned. (14)
The third component of the full medication system, BSMA at the patient's bedside, has not yet been installed in many hospitals. However, the United States Department of Veterans Affairs (VA) hospitals have been leading innovators with this technology and have reported decreased medication administration errors related to use of the system. There are no reports yet of BSMA system effectiveness in reducing preventable ADEs in the NICU. There are reports, however, from VA hospitals and others of negative effects attributed to the BSMA system, such as confusion of nurses by the automated removal of medications by the system, degraded coordination between nurses and physicians, nurses dropping activities to reduce workload during busy periods and giving priority to BSMA system-monitored activities when competing goals were encountered, (15) and "workarounds," such as scanning surrogate barcodes or scanning medication barcodes on doses at a scheduled time but not administering them until later. (16)
Smart Pumps
Infusion pump errors have been involved in MEs and ADEs, and human error in programming the pump has been a major source of the errors. A comparison of the actual medication, dose, and rate of infusion with the ordered medication, dose, and rate in a large academic medical center found that 66.9% had some discrepancy. (17) Most errors were not likely to cause harm. A current generation smart pump with software decision support was studied in adult cardiac surgical care and step-down units in a randomized time-series study design. (18) Under the conditions of the study, which permitted the nurses to bypass the pump drug library and to override the pump alerts, no difference in serious MEs (defined as nonintercepted potential ADEs and preventable ADEs) was found when smart pumps were used.
Larsen and associates (19) introduced a bundle of three interventions intended to improve the safety of continuous medication infusion in a tertiary pediatric hospital. The bundle included standard drug concentrations, smart pumps with software decision support, and human factors-engineered medication labels affixed to syringes by the pharmacy. Researchers selected a smart pump that met 13 rigorous selection criteria and purchased 340 pumps for the 242-bed hospital. The pharmacy discarded the previously used "rule of 6" to prepare customized solutions of medications to be infused, replacing it with standardized solutions for 32 common drugs. For most drugs, there were one or two standard solutions, but four standard concentrations were needed for two drugs. The third component of the package was a human factors-engineered label that highlighted in bold font the name of the patient, the drug name, the standard concentration used, and the dosing rate to be delivered, separated from other information on the label (Fig. 3). These four items were needed by the nurse to program the smart pumps, and human engineering principles were applied to format the label to match the pump programming sequence with easy-to-locate values.
|
| Low-tech Approaches to Medication Safety |
|---|
|
|
|---|
Low-tech efforts are effective in reducing MEs and ADEs. Cimino and associates (3) reported a decrease in preventable ADEs from 0.13% of all drug orders during a control period to 0.03% during a brief postintervention period (P<0.05) in 9 PICUs, each of which implemented one or more of 15 benchmarked interventions that were low- to moderate-tech.
| Intravascular Catheter Complications |
|---|
|
|
|---|
Butler-O'Hara and associates (25) compared the complication rate of two approaches to central venous catheter use in preterm infants whose birthweights were less than 1,251 g: in one arm of the randomized trial, they left umbilical vein catheters in place for as long as 28 days; in the other arm, they replaced the umbilical vein catheter with a percutaneously placed central venous line after 1 week. They found no difference in rates of complication, including infection.
Peripheral intravenous catheters may infiltrate, and if caustic fluids are being infused, infiltration may cause skin necrosis, an AE estimated to occur in as many as 4% of NICU patients. Reducing the risk of infiltration requires frequent checks of the insertion site and removal when early signs of infiltration are seen.
| Nosocomial Infections |
|---|
|
|
|---|
Fungi were identified as the pathogen in 12.2% of cases of late-onset sepsis in the Neonatal Research Network analysis, (26) with Candida sp being the most common. Prophylaxis with oral or systemic nystatin, miconazole, or fluconazole has been investigated. A Cochrane Database systematic review (28) found one trial of oral nystatin compared with no treatment in preterm infants that reported a significantly reduced relative risk of systemic fungal infection (relative risk [RR], 0.19; 95% confidence interval [CI], 0.04, 0.78); another trial comparing miconazole with placebo documented no effectiveness. No significant difference was shown in a third trial that compared oral fluconazole with nystatin. Another Cochrane Database systematic review (29) identified two trials of prophylactic intravenous fluconazole. Meta-analysis of the two found a reduced risk of death prior to hospital discharge for the infants who received fluconazole prophylaxis (RR, 0.44; 95% CI, 0.21, 0.91). A more recent report by Manzoni and colleagues (30) examined retrospectively the use of oral or intravenous fluconazole prophylaxis in very low-birthweight (VLBW) neonates for the first postnatal month during 2001 to 2003 compared with infants not given prophylaxis during 1998 to 2000. They reported a decrease in fungal colonization, a decrease in systemic fungal infections, and no change in the natively fluconazole-resistant fungi species.
Andersen and associates (31) showed a reduction in nosocomial bloodstream infections among VLBW infants following the introduction of a bundle of interventions that included: 1) replacement of a combination of povidone-iodine and isopropyl alcohol swabs by a 2% aqueous chlorhexidine solution for skin antisepsis prior to all central and peripheral catheter placements or invasive procedures in extremely low-birthweight infants until day 14 and by 1% chlorhexidine in ethanol for all other peripheral intravenous line placements, 2) introduction of a standardized sterile pack for line insertion, 3) removal of all peripheral lines after 48 hours, 4) removal of all intravascular lines when an infant achieved enteral feedings of 120 mL/kg per day, and 5) use of sterile technique when changing infusate solutions. Handwashing in the control period was based on individual preference. During the intervention period, workers were educated about handwashing, 4% chlorhexidine was used prior to procedures, and 2% chlorhexidine was used for routine handwashing. These changes were associated with a reduction in nosocomial bloodstream infections from 21% of infants in the 6 months prior to the interventions to 9% (P=0.05) in the 6 months after the bundle was implemented. However, four infants had severe skin irritation complications attributed to 2% chlorhexidine, one case of which progressed to exudation. Chlorhexidine-impregnated disks used over the catheter insertion sites of neonates in another trial also were associated with contact dermatitis, with an incidence of 15% in extremely low-birthweight infants. (32)
Endotracheal intubation and mechanical ventilation pose another route by which neonates may acquire a nosocomial infection. A 2004 Cochrane Database systematic review (33) found only one trial of insufficient quality regarding the use of prophylactic antibiotics in neonates receiving ventilation. A randomized clinical trial of immunoglobulin prophylaxis in ventilated neonates demonstrated no benefit in protection from nosocomial infection. (34)
A Cochrane Database systematic review (35) of granulocyte macrophage colony-stimulating factor prophylaxis for sepsis in preterm neonates found no benefit, except perhaps for those who had neutropenia or were likely to develop neutropenia.
| Fatigue and Human Error |
|---|
|
|
|---|
Lockley and associates (39) studied 20 internal medicine residents during two randomly assigned 3-week rotations in adult intensive care units, one of which was prior to the change in work hours and schedule and the other of which was after changes were made. In the rotation prior to the changes, most residents worked extended-duration shifts of more than 24 hours and more than 80 hours/wk. During the revised rotation, residents worked an average of 19.5 hours/wk less, slept 5.8 hours more, and had shifts of less than 24 hours duration. For the 11 PM to 7 AM shift of each type of rotation, the number of attentional failures per resident decreased from 5.5 per resident in the extended-duration schedule to 2.6 per resident during the revised, shorter rotation (P=0.02). Attentional failures were measured as intrusions of slow-rolling eye movements into polysomnographically confirmed episodes of wakefulness during work hours. In a companion study, Landrigan and colleagues (40) reported the rates of serious MEs made by the residents in the ICUs under the two working conditions. Serious MEs fell from 136.0/1,000 patient-days to 100.1/1,000 patient-days from the control to the revised rotations (P<0.001).
Barger and coworkers (41) conducted a Web-based survey in 2002 of first-year residents in multiple medical specialties of sufficient power to detect the effects of extended-hours shifts on preventable AEs. The odds ratios of reporting a preventable AE were significantly increased if the residents who participated in the survey had worked 1 month with one to four extended-duration shifts (odds ratio [OR], 8.7; 95% CI, 3.4, 22) compared with months when they worked none. First-year residents who worked five or more extended-duration shifts in a month reported 300% more preventable AEs that resulted in a patient death than when they worked a month with no extended-duration shifts. No comparable study of residents working in NICUs has been conducted, but Lee and associates (42) analyzed the mortality rate of neonates admitted at night with that of neonates admitted during the daytime working hours in the 17 Canadian Neonatal Network NICUs during 1996 through 1997 and found a higher risk-adjusted mortality rate for night admissions. Several reasons for this difference were speculated, including the effects of fatigue, as well as the variable availability of neonatologists and possible differences in nursing care at night.
| Handoffs, Communication Failure, and Cross-coverage |
|---|
|
|
|---|
An intriguing new approach to making medical handoffs demonstrably safer is described in detail by Catchpole and colleagues, (45) who adapted Formula 1 pit-stop and aviation models to improve the safety of handoffs of infants from cardiac surgery to the ICU. In brief, the investigators visited a Formula 1 team to observe pit-stop practice sessions from which they drew analogies with the handoff of a postoperative patient to the ICU. They developed new practices with anesthesiologists, surgeons, intensivists, and nurses that incorporated safety themes learned from the pit-stop crew work. These themes included leadership, task sequence, task allocation, prediction and planning, discipline and composure, and checklists. Further improvements in the protocol were made by aviation training captains who observed the medical handoff procedure. The investigators achieved improvements in all aspects of the handoffs: reduction in technical errors, information omissions, and time required. At least one consulting firm now offers to assist medical groups in applying aviation-based safety training to improve patient safety.
| Staffing Patterns, Workload, Tight Coupling, and AEs |
|---|
|
|
|---|
An optimal relationship of AEs adjusted for patient acuity is likely among census, the availability of open beds for admissions, and the numbers of admissions and discharges in an NICU, on the one hand, and the number and qualifications of the nursing and physician staff and their staffing patterns, on the other hand. Indeed, in other hospital venues, such a relationship has begun to emerge. Richardson (47) found increased adjusted hospital mortality at 10 days following periods of high emergency department occupancy that were associated with more presentations of patients in urgent triage categories and decreased treatment performance by standard measures. Weissman and coworkers (48) observed in an analysis of adult patients discharged from four hospitals that one hospital frequently experienced occupancy rates of more than 100%. In that hospital, but not the others, the likelihood of AEs was significantly associated with the numbers of admissions and patients per nurse. Their suggested explanation for this finding invokes the theory that organizations with high complexity and tight coupling or little "slack" (redundancy and buffering) lose resilience to additional interruptions. Until more definitive studies are conducted, expert opinion suggests that NICUs, as well as other ICUs, might operate optimally for patient safety at 75% to 85% of maximum occupancy.
| Building a Patient Safety Program |
|---|
|
|
|---|
|
The Vermont Oxford Network (VON) and the Center for Patient Safety in Neonatal Intensive Care have examined random safety audits in NICUs as another approach to assessment and improvement. This is an application of random process auditing adopted from other industries. Ursprung and colleagues (51) describe the use of a 36-item patient safety checklist on rounds three times each week to identify errors such as unlabeled medication at the bedside, a missing patient identification band, and inappropriate pulse oximeter settings. An abbreviated approach is to prepare a series of safety audit cards, one for each item on the checklist, and periodically select one at random to apply during rounds.
Stockwell and Slonim (52) have prepared an excellent introductory discussion of the contents of the "ICU Safety Tool Box" that ICU teams might employ to improve safety. These include, in order of increasing sophistication: incident reports, mortality and morbidity conferences, peer review, and root cause analysis (traditional tools for retrospective examination of care that was given) as well as failure mode and effects analysis, probabilistic risk assessment, and Six Sigma (prospective approaches for analyzing a complex system for possible sources of error and their likelihoods of occurrence, with the goal of avoiding such errors).
The Six Sigma approach seeks to reduce variability within a process, thereby reducing failures to 3.4 per 1 million opportunities. The steps are to define, measure, analyze, improve, and control a problem. This approach has been applied successfully to reduce catheter-related bloodstream infections in an academic surgical ICU from 11 to 1.7 infections per catheter. (53)
| Internet Resources for Building a Patient Safety Program |
|---|
|
|
|---|
The Institute of Healthcare Improvement (www.ihi.org) has a wealth of information, such as audio and Web-based programs. It also conducts education endeavors, including development programs for patient safety officers, and offers free tools, such as the Improvement Tracker (www.ihi.org/ihi/workspace/tracker). The Institute for Safe Medication Practices Web site (http://www.ismp.org) offers links to education content; tools such as lists of high-alert medications, confused drug names, and error-prone abbreviations; United States Food and Drug Administration safety alerts; and medication error reports and industry information about new medication safety products.
The Agency for Healthcare Research and Quality (AHRQ) supports a Patient Safety Network, PSNet (www.psnet.ahrq.gov), that provides a weekly update of journal articles about patient safety. The AHRQ also is a source of Pod casts that are available for downloading or for listening to directly (http://www.healthcare411.ahrq.gov). Topics include fatigue and errors, reducing catheter-related infections, medical handoffs, and medication errors in children. The Joint Commission (www.jointcommission.org/PatientSafety) and the Joint Commission International Center for Patient Safety (www.jcipatientsafety.org) are sources of sentinel event tools, alerts from other health-care settings, and descriptions of patient safety practices.
The VON sponsors an online quality improvement collaborative, iNICQ, with some programs focused specifically on patient safety measures, such as prevention of nosocomial infection or medication safety (www.vtoxford.org/home.aspx?p=/quality/inicq/schedule.htm).The Center for Patient Safety in Neonatal Intensive Care is a public-private consortium under the auspices of VON with support from the AHRQ that seeks to learn from errors and communicate that information to the neonatology community.
The Institute of Medicine of the National Academy of Sciences has published several authoritative volumes on patient safety, beginning with the landmark To Err is Human: Building a Safer Health System. More information about its Health Care Quality Initiative reports may be found at www.iom.edu/?id=35957.
| Conclusions |
|---|
|
|
|---|
| Footnotes |
|---|
Dr Morriss did not disclose any financial relationships relevant to this article.
| References |
|---|
|
|
|---|
2. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients.
JAMA. 2001;285
:2114
–2120
3. Cimino MA, Kirschbaum MS, Brodsky L, Shaha SH. Child Health Accountability Initiative. Assessing medication prescribing errors in pediatric intensive care units. Pediatr Crit Care Med. 2004;5 :124 –132[CrossRef][Medline]
4. Holdsworth MT, Fichtl RE, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients.
Arch Pediatr Adolesc Med. 2003;157
:60
–65
5. Upperman JS, Staley P, Friend K, et al. The impact of hospitalwide computerized physician order entry on medical errors in a pediatric hospital. J Pediatr Surg. 2005;40 :57 –59[CrossRef][Medline]
6. Luria JW, Muething SE, Schoettker PJ, Kotagal UR. Reliability science and patient safety. Pediatr Clin North Am. 2006;53 :1121 –1133[CrossRef][Medline]
7. Miller MR, Robinson KA, Lubomski LH, Rinke ML, Pronovost PJ. Medication errors in pediatric care: a systematic review of epidemiology and an evaluation of evidence supporting reduction strategy recommendations.
Qual Saf Health Care. 2007;16
:116
–126
8. Potts AL, Barr FE, Gregory DF, Wright L, Patel NR. Computerized physician order entry and medication errors in a pediatric critical care unit.
Pediatrics. 2004;113
:59
–63
9. Han YY, Carcillo JA, Venkataraman ST, et al. Unexpected increased mortality after implementation of a commercially sold computerized physician order entry system.
Pediatrics. 2005;116
:1506
–1512
10. Del Beccaro MA, Jeffries HE, Eisenberg MA, Harry ED. Computerized provider order entry implementation: no association with increased mortality rates in an intensive care unit.
Pediatrics. 2006;118
:290
–295
11. Koppel R, Metlay JP, Cohen A, et al. Role of computerized physician order entry systems in facilitating medication errors.
JAMA. 2005;293
:1197
–1203
12. Walsh KE, Adams WG, Bauchner H, et al. Medication errors related to computerized order entry for children.
Pediatrics. 2006;118
:1872
–1879
13. Zhan C, Hicks RW, Blanchette CM, Keyes MA, Cousins DD. Potential benefits and problems with computerized prescriber order entry: analysis of a voluntary medication error-reporting database.
Am J Health Syst Pharm. 2006;63
:353
–358
14. Poon EG, Cina JL, Churchill W, et al. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy.
Ann Intern Med. 2006;145
:426
–434
15. Patterson ES, Cook RI, Render ML. Improving patient safety by identifying side effects from introducing bar coding in medication administration.
J Am Med Inform Assoc. 2002;9
:540
–553
16. Patterson ES, Rogers ML, Chapman RJ, Render ML. Compliance with intended use of bar code medication administration in acute and long-term care: an observational study. Hum Factors. 2006;48 :15 –22[CrossRef][Medline]
17. Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology.
Qual Saf Health Care. 2005;14
:80
–86
18. Rothschild JM, Keohane CA, Cook EF, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33 :533 –540[CrossRef][Medline]
19. Larsen GY, Parker HB, Cash J, O'Connell M, Grant MC. Standard drug concentrations and smart-pump technology reduce continuous-medication-infusion errors in pediatric patients.
Pediatrics. 2005;116
:e21
–e25
20. Committee on Drugs and Committee on Hospital Care. Prevention of medication errors in the pediatric inpatient setting.
Pediatrics. 2003;112
:431
–436
21. Kozer E, Berkovitch, Koren G. Medication errors in children. Pediatr Clin North Am. 2006;53 :1155 –1168[CrossRef][Medline]
22. Hermansen MC, Hermansen MG. Intravascular catheter complications in the neonatal intensive care unit. Clin Perinatol. 2005;32 :141 –156[CrossRef][Medline]
23. Barrington KJ. Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database Syst Rev. 2000:CD000507
24. Barrington KJ. Umbilical artery catheters in the newborn: effects of position of the catheter tip. Cochrane Database Syst Rev. 2000:CD000505
25. Butler-O'Hara M, Buzzard CJ, Reubens L, McDermott MP, DiGrazio W, D'Angio CT. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams.
Pediatrics. 2006;118
:e25
–e35
26. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.
Pediatrics. 2002;110
:285
–291
27. Garland JS, Alex CP, Hendrickson KJ, McAuliffe TL, Maki DG. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Pediatrics. 2005;116
:e198
–e205
28. Austin NC, Darlow B. Prophylactic oral antifungal agents to prevent systemic Candida infection in preterm infants. Cochrane Database Syst Rev. 2004:CD003478
29. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2004:CD003850
30. Manzoni P, Arisio R, Mostert M, et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
Pediatrics. 2006;117
:e22
–e32
31. Andersen C, Hart J, Vemgal P, Harrison C. Prospective evaluation of a multi-factorial prevention strategy on the impact of nosocomial infection in very-low-birthweight infants. J Hosp Infect. 2005;61 :162 –167[CrossRef][Medline]
32. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Pediatrics. 2001;107
:1431
–1436
33. Inglis GD, Davies MW. Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants. Cochrane Database Syst Rev. 2004:CD004338
34. Adhikari M, Wesley AG, Fourie PB. Intravenous immunoglobulin prophylaxis in neonates on artificial ventilation. S Afr Med J. 1996;86 :542 –545[Medline]
35. Carr R, Modi N, Dore C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev. 2003:CD003066
36. Parshuram CS. The impact of fatigue on patient safety. Pediatr Clin North Am. 2006;1135 –1153
37. Dawson D, Reid K. Fatigue, alcohol and performance impairment. Nature. 1997;388 :235[Medline]
38. Philibert I. Sleep loss and performance in residents and nonphysicians: a meta-analytic examination. Sleep. 2005;28 :1392 –1402[Medline]
39. Lockley SW, Cronin JW, Evans EE, et al. Effect of reducing interns' weekly work hours on sleep and attentional failures.
N Engl J Med. 2004;351
:1829
–1837
40. Landrigan CP, Rothschild JM, Cronin JW, et al. Effect of reducing interns work hours on serious medical errors in intensive care units.
N Engl J Med. 2004;351
:1838
–1848
41. Barger LK, Ayas NT, Cade BE, et al. Impact of extended-duration shifts on medical errors, adverse events, and attentional failures. PLoS Med. 2006;3 :e487 .[CrossRef][Medline]
42. Lee SK, Lee DSC, Andrews WL, et al. Higher mortality rates among inborn infants admitted to neonatal intensive care units at night. J Pediatr. 2003;143 :592 –597[CrossRef][Medline]
43. Petersen LA, Orav EJ, Teich JM, O Neil AC, Brennan TA. Using a computerized sign-out program to improve continuity of inpatient care and prevent adverse events. Jt Comm J Qual Improv. 1998;24 :77 –87[Medline]
44. Streitenberger K, Breen-Reid K, Harris C. Handoffs in care–can we make them safer? Pediatr Clin North Am. 2006;53 :1185 –1195[CrossRef][Medline]
45. Catchpole KR, de Leval MR, McEwan A, et al. Patient handover from surgery to intensive care: using Formula 1 pit-stop and aviation models to improve safety and quality. Paediatr Anaesth. 2007;17 :470 –478[CrossRef][Medline]
46. The UK Neonatal Staffing Study Group. Patient volume, staffing, and workload in relation to risk-adjusted outcomes in a random stratified sample of UK neonatal intensive care units: a prospective evaluation. Lancet. 2002;359 :99 –107[CrossRef][Medline]
47. Richardson DB. Increase in patient mortality at 10 days associated with emergency department overcrowding. Med J Aust. 2006;184 :213 –216[Medline]
48. Weissman JS, Rothschild JM, Bendavid R, et al. Hospital workload and adverse events. Med Care. 2007;45 :448 –455[CrossRef][Medline]
49. Stevens P, Matlow A, Laxer RM. Blueprint for patient safety. Pediatr Clin North Am. 2006;53 :1253 –1267[CrossRef][Medline]
50. Griffin FA, Resar RK. IHI Global Trigger Tool for Measuring Adverse Events. IHI Innovation Series white paper. Cambridge, Mass: Institute for Healthcare Improvement; 2007. Available at: www.IHI.org
51. Ursprung R, Gray JE, Edwards WH, et al. Real time patient safety audits: improving safety every day.
Qual Saf Health Care. 2005;14
:284
–289
52. Stockwell DC, Slonim AD. Quality and safety in the intensive care unit.
J Intensive Care Med. 2006;21
:199
–210
53. Frankel HL, Crede WB, Topal JE, Roumanis SA, Devlin MW, Foley AB. Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU. J Am Coll Surg. 2005;201 :349 –358[CrossRef][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |